Copthorne Tara Hotel
Scarsdale Pl, Kensington
Chaired by the regulatory expert, Michel Mikhail, this meeting will look at the global market for biosimilar medicines which is expected to grow rapidly with the loss of patent protection for the earliest antibody and protein therapeutics. The biosimilars' market is expected to reach $23.6 billion by 2023, growing at a compound annual rate of 31.7%. Driving this growth are lower prices for these medicines relative to the originator drugs and the ongoing incidence of chronic diseases. Collaborations among developers are also resulting in more clinical trials and enhanced productivity.
The meeting will also look at future regulatory, commercial and legal challenges in relation to the uptake of biosimilar medicines.